to answer your first question in a round about way, my understanding is that the "innovative" process is currently only being used for CuTi trial products, and the rest of the products being offered for sale are being produced by the traditional process.
I stand corrected if I'm wrong, but that's the way i read it, R.
Ann: Quarterly Activities/Appendix 5B Cash Flow Report, page-31
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
72.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $145.6M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1388 | 72.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 72.0¢ | 12801 | 1 |
View Market Depth
| Last trade - 07.35am 25/07/2025 (20 minute delay) ? |
| ASM (ASX) Chart |
Day chart unavailable